- Home
- BNR vs NTWK Comparison
BNR vs NTWK Comparison
Compare BNR & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- NTWK
- Stock Information
- Founded
- BNR 2014
- NTWK 1997
- Country
- BNR China
- NTWK United States
- Employees
- BNR N/A
- NTWK N/A
- Industry
- BNR Medical Specialities
- NTWK Computer Software: Prepackaged Software
- Sector
- BNR Health Care
- NTWK Technology
- Exchange
- BNR Nasdaq
- NTWK Nasdaq
- Market Cap
- BNR 30.9M
- NTWK 28.0M
- IPO Year
- BNR 2020
- NTWK 1998
- Fundamental
- Price
- BNR $2.84
- NTWK $2.47
- Analyst Decision
- BNR
- NTWK
- Analyst Count
- BNR 0
- NTWK 0
- Target Price
- BNR N/A
- NTWK N/A
- AVG Volume (30 Days)
- BNR 17.2K
- NTWK 22.1K
- Earning Date
- BNR 05-28-2025
- NTWK 05-08-2025
- Dividend Yield
- BNR N/A
- NTWK N/A
- EPS Growth
- BNR N/A
- NTWK N/A
- EPS
- BNR N/A
- NTWK N/A
- Revenue
- BNR $70,669,261.00
- NTWK $62,048,128.00
- Revenue This Year
- BNR $136.32
- NTWK N/A
- Revenue Next Year
- BNR N/A
- NTWK N/A
- P/E Ratio
- BNR N/A
- NTWK N/A
- Revenue Growth
- BNR N/A
- NTWK 9.28
- 52 Week Low
- BNR $2.62
- NTWK $2.14
- 52 Week High
- BNR $8.99
- NTWK $3.34
- Technical
- Relative Strength Index (RSI)
- BNR 23.18
- NTWK 56.24
- Support Level
- BNR $2.77
- NTWK $2.32
- Resistance Level
- BNR $3.48
- NTWK $2.48
- Average True Range (ATR)
- BNR 0.35
- NTWK 0.13
- MACD
- BNR 0.04
- NTWK 0.02
- Stochastic Oscillator
- BNR 5.93
- NTWK 90.28
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.